Americann Stock

Americann Current Ratio

The Current Ratio of Americann (ACAN) as of Sep 7, 2026 is 0.03. In the previous year, Current Ratio was 0.22 — a change of -84.88% (lower).

Current Ratio

0.03

YoY

-84.88%

Last updated:

Current Ratio of Americann is 2026 0.03 . Current Ratio of Americann was 2025 0.22 . It decreases by -84.88% lower compared to the previous year.
Access this data via the Eulerpool API

Americann Stock analysis

What does Americann do? Americann Inc is a US-based company that specializes in the legalization and cultivation of cannabis-based products. It was founded in 2010 by Tim Keogh, an experienced entrepreneur and investor. Americann's business model focuses on creating value through investments in various sectors of the cannabis industry. This includes companies involved in cultivation and production, technology and innovation, as well as sales and distribution. The company aims to achieve diversification in its investments to create long-term value for its investors. Americann does not offer its own products or services, but instead invests in companies within the cannabis industry. Americann is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Americann stock

Current Ratio of Americann is 0.03 in 2026.

Current Ratio of Americann changed from 0.22 to 0.03, representing a -84.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Americann since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Americann with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Americann

All Key Metrics — Americann